Concurrent Arterial and Venous Thromboembolism While Receiving an Aromatase Inhibitor
A 49-year-old man presented with concurrent and widespread arterial and venous thromboembolism following a recent commencement of aromatase inhibitor therapy. Investigations revealed bilateral renal infarctions, complete occlusion of the superior mesenteric artery, and bilateral pulmonary emboli. He...
Saved in:
| Main Authors: | Ibrahim Shahid, Jiwoo Lee, Samko Jamriska, Thuy Le |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2024-08-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2024.0296 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Venous and arterial thrombosis in patients receiving immune checkpoint inhibitors.
by: Anouk van Lent, et al.
Published: (2025-01-01) -
How to reduce a risk of venous thromboembolism while taking combined oral contraceptives
by: V. O. Bitsadze, et al.
Published: (2023-07-01) -
Postoperative venous thromboembolism in transgender patients receiving estrogen-based hormone therapy
by: Ethan C. Kelmser, MS, et al.
Published: (2025-05-01) -
Immune checkpoint inhibitor-associated risk for venous thromboembolism: a comprehensive analysis
by: Jean M Connors, et al.
Published: (2025-05-01) -
Overall Survival With Palbociclib and Aromatase Inhibitor Versus Aromatase Inhibitor Alone in Older Patients With HR+/HER2− Metastatic Breast Cancer
by: Adam M. Brufsky, et al.
Published: (2025-04-01)